| Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 597.03B | 551.88B | 521.40B | 492.23B | 489.09B |
| Gross Profit | 139.64B | 124.02B | 118.27B | 114.09B | 119.49B |
| EBITDA | 71.73B | 63.50B | 59.94B | 56.73B | 61.10B |
| Net Income | 33.26B | 27.11B | 26.63B | 23.23B | 28.23B |
Balance Sheet | |||||
| Total Assets | 675.02B | 572.40B | 571.46B | 520.99B | 492.45B |
| Cash, Cash Equivalents and Short-Term Investments | 167.38B | 150.68B | 151.23B | 143.65B | 148.50B |
| Total Debt | 94.12B | 54.74B | 50.58B | 53.83B | 54.26B |
| Total Liabilities | 248.08B | 196.40B | 193.70B | 186.91B | 174.38B |
| Stockholders Equity | 383.63B | 338.43B | 344.10B | 305.07B | 290.71B |
Cash Flow | |||||
| Free Cash Flow | 18.48B | 30.28B | 33.37B | 23.32B | 35.53B |
| Operating Cash Flow | 53.79B | 45.13B | 47.79B | 38.48B | 48.64B |
| Investing Cash Flow | -39.21B | -15.55B | -16.48B | -24.82B | -14.09B |
| Financing Cash Flow | -7.75B | -36.31B | -21.94B | -19.38B | -18.18B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥297.30B | 21.26 | ― | 2.42% | 4.46% | 23.01% | |
66 Neutral | ¥10.55B | 39.86 | ― | ― | 18.12% | 53.11% | |
65 Neutral | ¥573.58B | 16.45 | ― | 2.14% | 8.18% | 23.30% | |
64 Neutral | ¥2.82T | 22.84 | 8.35% | 1.77% | 4.75% | 6.22% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
62 Neutral | ¥4.35B | 6.76 | ― | 3.03% | 14.54% | ― | |
62 Neutral | ¥37.94B | 14.21 | ― | 1.95% | 10.26% | -21.50% |